| P50 | author | Cynthia E. Dunbar | Q52883652 |
| P2093 | author name string | A J Barrett | |
| | T J Walsh | |
| | N S Young | |
| | J F Tisdale | |
| | N Geller | |
| | D E Dunn | |
| | M Plante | |
| | O Nunez | |
| | S J Rosenfeld | |
| P2860 | cites work | Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience | Q33839006 |
| | Late clonal diseases of treated aplastic anemia | Q33839018 |
| | The pathophysiology of acquired aplastic anemia | Q34739892 |
| | Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma | Q35821534 |
| | In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus | Q35823358 |
| | Infection and cyclosporine | Q38717664 |
| | Current therapies for systemic vasculitis | Q40501858 |
| | Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party | Q41065906 |
| | Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group | Q44262944 |
| | Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum | Q50417610 |
| | Recovery from aplastic anemia after treatment with cyclophosphamide | Q67869070 |
| | Screening of cytotoxic drugs for residual bone marrow damage | Q68215205 |
| | Correlation of clinical and immunologic states in multiple sclerosis | Q70025188 |
| | Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia | Q71268640 |
| | Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone | Q71493848 |
| | Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same | Q72160665 |
| | The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis | Q72811565 |
| | Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia | Q73005992 |
| | Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes | Q73023204 |
| | Antithymocyte globulin for patients with myelodysplastic syndrome | Q73945799 |
| | Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group | Q77320912 |
| P433 | issue | 9241 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1554-1559 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial | |
| P478 | volume | 356 | |